Relationship of Breast Cancer Susceptibility with Rs6257 and Rs6258 Polymorphisms in the SHBG Gene


Breast cancer
Sex hormone-binding globulin (SHBG)
Single nucleotide polymorphism

How to Cite

Shirzad, S. ., Tahmasebi Fard, zahra, & Jamaldini, S. H. . (2020). Relationship of Breast Cancer Susceptibility with Rs6257 and Rs6258 Polymorphisms in the SHBG Gene . Iranian Red Crescent Medical Journal, 22(10).


Background: Breast cancer is a hormone-dependent malignancy. Sex hormone-binding globulin (SHBG) is the main transport binding protein for sex steroid hormones in plasma and regulates their accessibility to target cells.

Objective: The present study aimed to assess the relationship between rs6257 and rs6258 polymorphisms in the SHBG gene with breast cancer risk.

Materials and Methods: This case-control study was conducted on 100 breast cancer patients and 100 healthy control subjects. After extracting DNA from peripheral blood, Genotyping was performed using the polymerase chain reaction-restriction fragment length polymorphism method. The data were analyzed in SPSS software using the chi-square test and logistic regression to distinguish the difference between the cases and controls in terms of the distribution of allele types and genotypes.

Results: The frequencies of Rs6257 were 78%, 17%, 5% in the case group and 88%, 7%, and 5% in control groups for TT, CC, and CT genotypes respectively. The rs6257 CC genotype showed about a 2.721-fold increase in breast cancer (P=0.030, OR:2.721, CI95%:1.075-6.887). This genotype was reversely associated with age, body mass index, menopausal status, and breast cancer. Nonetheless, Rs6258 had no significant correlation with breast cancer risk or other demographic factors.

Conclusions: As evidenced by the obtained results, the rs6257 polymorphism may be a useful biomarker associated with breast cancer risk in Iranian women. To confirm the findings of the present study, larger studies are needed in the future.


  1. Ghoncheh M, Pournamdar Z, Salehiniya H. Incidence and mortality and epidemiology of breast cancer in the world. Asian Pac J Cancer Prev. 2016;17(S3):43-6. doi: 10.7314/apjcp.2016.17.s3.43. [PubMed: 27165206].
  2. Clendenen T, Zeleniuch-Jacquotte A, Wirgin I, Koenig KL, Afanasyeva Y, Lundin E, et al. Genetic variants in hormone-related genes and risk of breast cancer. PLoS One. 2013;8(7):e69367. doi: 10.1371/journal.pone.0069367. [PubMed: 23935996].
  3. Mavaddat N, Antoniou AC, Easton DF, Garcia-Closas M. Genetic susceptibility to breast cancer. Mol Oncol. 2010;4(3):174-91. doi: 10.1016/j.molonc.2010.04.011. [PubMed: 20542480].
  4. Riancho JA, Valero C, Zarrabeitia MT, Garcia-Unzueta MT, Amado JA, Gonzalez-Macias J. Genetic polymorphisms are associated with serum levels of sex hormone binding globulin in postmenopausal women. BMC Med Genet. 2008;9:112. doi: 10.1186/1471-2350-9-112. [PubMed: 19091090].
  5. Kahn SM, Hryb DJ, Nakhla AM, Romas NA, Rosner W. Beyond carrier proteins: sex hormone-binding globulin is synthesized in target cells. J Endocrinol. 2002;175:113-20.
  6. Berube D, Seralini GE, Gagne R, Hammond GL. Localization of the human sex hormone-binding globulin gene (SHBG) to the short arm of chromosome 17 (17p12----p13). Cytogenet Cell Genet. 1990;54(1-2):65-7. doi: 10.1159/000132958. [PubMed: 2249477].
  7. Pugeat M, Nader N, Hogeveen K, Raverot G, Déchaud H, Grenot C. Sex hormone-binding globulin gene expression in the liver: drugs and the metabolic syndrome. Mol Cell Endocrinol. 2010;316(1):53-9. doi: 10.1016/j.mce.2009.09.020. [PubMed: 19786070].
  8. Eriksson AL, Lorentzon M, Mellstrom D, Vandenput L, Swanson C, Andersson N, et al. SHBG gene promoter polymorphisms in men are associated with serum sex hormone-binding globulin, androgen and androgen metabolite levels, and hip bone mineral density. J Clin Endocrinol Metab. 2006;91(12):5029-37. doi: 10.1210/jc.2006-0679. [PubMed: 16926255].
  9. Hammond GL. Molecular properties of corticosteroid binding globulin and the sex-steroid binding proteins. Endocr Rev. 1990;11(1):65-79. doi: 10.1210/edrv-11-1-65. [PubMed: 2180688].
  10. Breast Cancer Association Consortium. Commonly studied single-nucleotide polymorphisms and breast cancer: results from the Breast Cancer Association Consortium. J Natl Cancer Inst. 2006;98(19):1382-96. doi: 10.1093/jnci/djj374. [PubMed: 17018785].
  11. Thompson DJ, Healey CS, Baynes C, Kalmyrzaev B, Ahmed S, Dowsett M, et al. Identification of common variants in the SHBG gene affecting sex hormone binding globulin levels and breast cancer risk in postmenopausal women. Cancer Epidemiol Biomarkers Prev. 2008;17(12):3490-8. doi: 10.1158/1055-9965.EPI-08-0734. [PubMed: 19064566].
  12. Shulman LN, Willett W, Sievers A, Knaul FM. Breast cancer in developing countries: opportunities for improved survival. J Oncol. 2010;2010:595167. doi: 10.1155/2010/595167. [PubMed: 21253541].
  13. Quan L, Hong CC, Zirpoli G, Roberts MR, Khoury T, Sucheston-Campbell LE, et al. Variants of estrogen-related genes and breast cancer risk in European and African American women. Endocr Relat Cancer. 2014;21(6):853-64. doi: 10.1530/ERC-14-0250. [PubMed: 25228414].
  14. Noguera NI, Tallano CE, Bragos IM, Milani AC. Modified salting-out method for DNA isolation from newborn cord blood nucleated cells. J Clin Lab Anal. 2000;14(6):280-3. doi:10.1002/1098-2825(20001212)14:6<280::AID-JCLA6>3.0.CO;2-0. [PubMed: 11138610].
  15. Fortunati N, Catalano MG. Sex hormone-binding globulin (SHBG) and estradiol cross-talk in breast cancer cells. Horm Metab Res. 2006;38(4):236-40. doi: 10.1055/s-2006-925337. [PubMed: 16700004].
  16. Catalano MG, Costantino L, Frairia R, Boccuzzi G, Fortunati N. Sex hormone-binding globulin selectively modulates estradiol-regulated genes in MCF-7 cells. Horm Metab Res. 2007;39(4):288-94. doi: 10.1055/s-2007-973814. [PubMed: 17447168].
  17. Freedman ND, Ahn J, Hou L, Lissowska J, Zatonski W, Yeager M, et al. Polymorphisms in estrogen- and androgen-metabolizing genes and the risk of gastric cancer. Carcinogenesis. 2009;30(1):71-7. doi: 10.1093/carcin/bgn258. [PubMed: 19015200].
  18. Fortunati N, Catalano MG, Boccuzzi G, Frairia R. Sex hormone-binding globulin (SHBG), estradiol and breast cancer. Mol Cell Endocrinol. 2010;316(1):86-92. doi: 10.1016/j.mce.2009.09.012. [PubMed: 19770023].
  19. Xita N, Tsatsoulis A. Genetic variants of sex hormone-binding globulin and their biological consequences. Mol Cell Endocrinol. 2010;316(1):60-5. doi: 10.1016/j.mce.2009.08.025. [PubMed: 19733622].
  20. Key TJ. Endogenous oestrogens and breast cancer risk in premenopausal and postmenopausal women. Steroids. 2011;76(8):812-5. doi: 10.1016/j.steroids.2011.02.029. [PubMed: 21477610].
  21. Zhou JY, Shi R, Yu HL, Zheng WL, Ma WL. Association between SHBG Asp327Asn (rs6259) polymorphism and breast cancer risk: a meta-analysis of 10,454 cases and 13,111 controls. Mol Biol Rep. 2012;39(8):8307-14. doi: 10.1007/s11033-012-1680-2. [PubMed: 22711300].